Brief: Effector Therapeutics -On Feb 28, Got Second Letter From Nasdaq Stating Co Had Been Granted Additional 180 Days To Regain Compliance With Nasdaq
March 6 (Reuters) - eFFECTOR Therapeutics Inc EFTR.O :
* EFFECTOR THERAPEUTICS -ON FEB 28, GOT SECOND LETTER FROM
NASDAQ
STATING CO HAD BEEN GRANTED ADDITIONAL 180 DAYS TO REGAIN
COMPLIANCE WITH NASDAQ
Further company coverage: EFTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Effector Therapeutics
See all newsBrief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright